BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12764404)

  • 1. How well are hypertension and albuminuria treated in type II diabetic patients?
    Boero R; Prodi E; Elia F; Porta L; Martelli S; Ferraro L; Quarello F
    J Hum Hypertens; 2003 Jun; 17(6):413-8. PubMed ID: 12764404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus].
    Boero R; Prodi E; Borsa S; Berti V; Fiorio E; Ferraro L; Massara C; Quarello F
    G Ital Nefrol; 2002; 19(4):413-8. PubMed ID: 12369043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME
    J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
    Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
    Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
    J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New treatment guidelines for a patient with diabetes and hypertension.
    Mogensen CE
    J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arterial hypertension management in patients with type 2 diabetes].
    Charpentier G; Genès N; Vaur L; Clerson P; Amar J; Guéret P; Cambou JP
    Arch Mal Coeur Vaiss; 2002; 95(7-8):661-5. PubMed ID: 12365076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.
    Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
    Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of blood pressure level over a three years period in non-insulin dependent diabetic subjects according to their microalbuminuria].
    Mayaudon H; Bauduceau B; Ducorps M; Belmejdoub G; Poirier JM
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1045-9. PubMed ID: 8949376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of doxazosin on ambulatory blood pressure and sympathetic nervous activity in hypertensive Type 2 diabetic patients with overt nephropathy.
    Yasuda G; Hasegawa K; Kuji T; Ogawa N; Shimura G; Umemura S; Tochikubo O
    Diabet Med; 2005 Oct; 22(10):1394-400. PubMed ID: 16176202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial.
    Marre M; Garcia Puig J; Kokot F; Fernandez M; Jermendy G; Opie L; Moyseev V; Scheen A; Ionescu-Tirgoviste C; Saldanha MH; Halabe A; Williams B; Mion D; Ruiz M; Hermansen K; Tuomilehto J; Finizola B; Pozza G; Chastang C; Ollivier JP; Amouyel P; Asmar R
    J Hypertens Suppl; 2003 Mar; 21(1):S19-24. PubMed ID: 12769163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes: evaluation using home-based blood pressure measurements.
    Kamoi K; Ikarashi T
    Clin Exp Hypertens; 2005 May; 27(4):369-76. PubMed ID: 15921073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renoprotective effect and cost-effectiveness of using benidipine, a calcium channel blocker, to lower the dose of angiotensin receptor blocker in hypertensive patients with albuminuria.
    Saito F; Fujita H; Takahashi A; Ichiyama I; Harasawa S; Oiwa K; Takahashi N; Otsuka Y; Uchiyama T; Kanmatsuse K; Kushiro T
    Hypertens Res; 2007 Jan; 30(1):39-47. PubMed ID: 17460370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension management in outpatient visits by diabetic patients.
    Aparasu RR; Aparasu A
    Res Social Adm Pharm; 2008 Sep; 4(3):284-91. PubMed ID: 18794038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor hypertension control in Greek patients with diabetes in rural areas. The VANK study in primary care.
    Skliros E; Sotiropoulos A; Vasibossis A; Xipnitos C; Chronopoulos I; Razis N; Merkouris P
    Rural Remote Health; 2007; 7(3):583. PubMed ID: 17617008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is renoprotection by angiotensin receptor blocker dependent on blood pressure?: the Saitama Medical School, Albuminuria Reduction in Diabetics with Valsartan (STAR) study.
    Katayama S; Yagi S; Yamamoto H; Yamaguchi M; Izumida T; Noguchi Y; Inaba M; Inukai K
    Hypertens Res; 2007 Jun; 30(6):529-33. PubMed ID: 17664856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
    Tilly B; Guilhot J; Salanave B; Fender P; Allemand H
    Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.